Search
for
Sort by
Research 421–450 of 702
- Affect of a six months treatment regiment of metformin (MET) on 17-hydroxyprogesterone (17P) responses to GnRH agonist (GnRH Ag) in polycystic ovary syndrome (PCOS)
- Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Management of Transgenderism
- Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*
- Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5<i>α</i>-Reductase Activity and Androgen Receptor Content*
- Intratesticular Control Of Steroidogenesis
- Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗
- Polycystic ovary syndrome and impact on health
- Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
- Kisspeptin and LH pulsatile temporal coupling in PCOS patients
- Differential Suppression of Testosterone and Estradiol in Hirsute Women With the Superactive Gonadotropin-Releasing Hormone Agonist Leuprolide*
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- Cardiovascular Toxicities of Androgen Deprivation Therapy
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Effects of Prenatal Treatment with Antiandrogens on Luteinizing Hormone Secretion and Sex Steroid Concentrations in Adult Spotted Hyenas, Crocuta crocuta1
- Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin
- Interventions for hirsutism (excluding laser and photoepilation therapy alone)
- Anti-androgen Treatments
- Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study.
- The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response
- 9 Diagnosis and therapy of hyperandrogenism
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy
- Medical Options for Care of Gender Diverse and Transgender Youth
- Approach to androgen excess in women: Clinical and biochemical insights
- Precocious Puberty
- The Evaluation and Management of Hirsutism
- Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
- What do we know about abnormally low prolactin levels in polycystic ovary syndrome? A narrative review